Figures & data
Figure 1 E2F8 is upregulated in ESCC.
Abbreviations: ESCC, esophageal squamous cell carcinoma; T, tumor tissues; N, adjacent non-tumor tissues; qRT-PCR, quantitative real-time PCR.
![Figure 1 E2F8 is upregulated in ESCC.](/cms/asset/560ac427-79eb-42cf-b18e-3ed8dfc0f1b9/dott_a_180938_f0001_b.jpg)
Figure 2 E2F8 promotes ESCC cell proliferation and arrests cell cycle at S phase.
Abbreviations: ESCC, esophageal squamous cell carcinoma; qRT-PCR, quantitative real-time PCR; CCK-8, Cell Counting Kit-8; EdU, 5-ethynyl-2′-deoxyuridine; NC, negative control.
![Figure 2 E2F8 promotes ESCC cell proliferation and arrests cell cycle at S phase.](/cms/asset/a56d5577-e528-478e-b7cb-23b8f548aa83/dott_a_180938_f0002_c.jpg)
![Figure 2 E2F8 promotes ESCC cell proliferation and arrests cell cycle at S phase.](/cms/asset/539bbfdc-f360-459b-a046-973cf668d824/dott_a_180938_f0002a_c.jpg)
Figure 3 Effects of E2F8 on the expression of CCND1/p21.
Abbreviations: qRT-PCR, quantitative real-time PCR; NC, negative control.
![Figure 3 Effects of E2F8 on the expression of CCND1/p21.](/cms/asset/6c1cf250-2473-4fd4-bd3e-54f3f52df1d4/dott_a_180938_f0003_b.jpg)
Figure 4 Downregulated E2F8 inhibits tumorigenicity in vivo.
Abbreviation: NC, negative control.
![Figure 4 Downregulated E2F8 inhibits tumorigenicity in vivo.](/cms/asset/e3b97540-e3aa-4600-a998-b1461b2fed4d/dott_a_180938_f0004_c.jpg)